This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

SAVE UP TO $700 IF YOU BOOK BEFORE JULY 17 2021

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San Diego

Maria Jure-Kunkel, Ph.D.
Head of Late Stage Oncology Translational Medicine at Genmab

Profile

Maria Jure-Kunkel is currently the Head of Late Stage Translational Research at Genmab. Prior to that, she led Translational Medicine and Discovery/Translational Research teams at MedImmune/AstraZeneca and at Bristol-Myers Squibb. In her 20+ years of pharmaceutical experience, Maria has been the recipient of several patents in the field of Immuno-Oncology and had the privilege to contribute to the development of several IO agents including urelumab, ipilimumab and nivolumab.

Agenda Sessions

  • DuoBody®-PD-L1x4-1BB [GEN1046]: Next Generation Checkpoint Immunotherapy Combining PD-1/PD-L1 Blockade with Conditional 4-1BB T-cell Activation

    On Demand
  • Transforming Therapeutic Targets

    10:15am